Use of dasatinib in chronic myeloid leukemia therapy

Use of dasatinib in chronic myeloid leukemia therapy

.

Bibliographic Details
Main Authors:	O. Yu. Vinogradova, A. G. Turkina, N. D. Choroshko
Format:	Article
Language:	English
Published:	Siberian State Medical University (Tomsk) 2008-12-01
Series:	Bûlleten' Sibirskoj Mediciny
Online Access:	https://bulletin.tomsk.ru/jour/article/view/3930

Similar Items

DASATINIB IN CHRONIC MYELOID LEUKEMIA
by: Mojca Modic
Published: (2008-04-01)

Systematic review of dasatinib in chronic myeloid leukemia
by: Breccia M, et al.
Published: (2013-03-01)

Dasatinib in chronic myeloid leukemia: a review
by: Dolly G Aguilera, et al.
Published: (2009-03-01)

Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia
by: Radhakrishnan Ramchandren, et al.
Published: (2009-05-01)

Dasatinib treatment of imatinib-resistant and imatinib-intolerant patients with chronic myeloid leukemia in a chronic phase
by: Ol'ga Yur'evna Vinogradova, et al.
Published: (2009-07-01)

The role of dasatinib in the management of chronic myeloid leukemia
by: Chen R, et al.
Published: (2015-02-01)

Dasatinib in First- and Second-Line Therapy of Chronic Myeloid Leukemia: Efficacy, Safety and Quality of Life
by: TI Ionova, et al.
Published: (2017-04-01)

First-line therapy of chronic myeloid leukemia &ndash; focus on dasatinib
by: Amrein PC
Published: (2012-04-01)

Skin lesions in chronic myeloid leukemia patients during dasatinib treatment
by: Tarantini F, et al.
Published: (2019-08-01)

Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy
by: Monika Conchon, et al.
Published: (2010-01-01)

Cytomegalovirus colitis with presentation of hemorrhagic colitis in chronic myeloid leukemia during dasatinib therapy
by: Tzer-Ming Chuang, et al.
Published: (2021-04-01)

Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations
by: Keskin D, et al.
Published: (2016-10-01)

Efficacy and Tolerability after Unusually Low Doses of Dasatinib in Chronic Myeloid Leukemia Patients Intolerant to Standard-Dose Dasatinib Therapy
by: Mariana Serpa, et al.
Published: (2010-01-01)

Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinib
by: Charles Chuah, et al.
Published: (2009-04-01)

First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib
by: Rafiyath Shamudheen, et al.
Published: (2010-11-01)

Cytomegalovirus-induced Hemorrhagic Colitis in a Patient with Chronic Myeloid Leukemia (Chronic Phase) on Dasatinib as an Upfront Therapy
by: Mohamed A. Yassin, et al.
Published: (2015-01-01)

Cytomegalovirus-induced Hemorrhagic Colitis in a Patient with Chronic Myeloid Leukemia (Chronic Phase) on Dasatinib as an Upfront Therapy
by: Mohamed A. Yassin, et al.
Published: (2015-08-01)

Efficacy and safety of tyrosine kinase inhibitors (dasatinib, nilotinib) in the treatment of chronic phase chronic myeloid leukemia
by: E. G. Lomaia, et al.
Published: (2014-07-01)

Efficacy and safety of tyrosine kinase inhibitors (dasatinib, nilotinib) in the treatment of chronic phase chronic myeloid leukemia
by: E. G. Lomaia, et al.
Published: (2014-07-01)

Optic neuropathy secondary to dasatinib in the treatment of a chronic myeloid leukemia case
by: Katia Sotelo Monge, et al.
Published: (2015-07-01)

Physicians’ attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients
by: Massimo Breccia, et al.
Published: (2017-10-01)

Dasatinib Induced Avascular Necrosis of Femoral Head in Adult Patient with Chronic Myeloid Leukemia
by: Mohamed A. Yassin, et al.
Published: (2015-01-01)

Dasatinib Induced Avascular Necrosis of Femoral Head in Adult Patient with Chronic Myeloid Leukemia
by: Mohamed A. Yassin, et al.
Published: (2015-07-01)

Assessment of Dasatinib Versus Nilotinib as Upfront Therapy for Chronic Phase of Chronic Myeloid Leukemia in Qatar: A Cost-Effectiveness Analysis
by: Ahmad Adel MSc, et al.
Published: (2021-04-01)

Economic evaluation of dasatinib in the treatment of chronic myeloid leukemia patients resistant to imatinib in Chile
by: Milva Caputo, et al.
Published: (2011-04-01)

Dasatinib-Induced Rhabdomyolysis in a 33-Year-Old Patient with Chronic Myeloid Leukemia
by: Andrew Stevenson Joel Chandranesan, et al.
Published: (2018-01-01)

Isolated central nervous system blast crisis in a case of chronic myeloid leukemia on dasatinib
by: P K Kiran, et al.
Published: (2018-01-01)

Clinical significance of dasatinib-induced pleural effusion in patients with de novo chronic myeloid leukemia
by: Aya Nakaya, et al.
Published: (2018-09-01)

Long lasting complete molecular remission after suspending dasatinib treatment in chronic myeloid leukemia
by: Gadó Klára, et al.
Published: (2012-07-01)

Dasatinib: clinical trials and management of adverse events in imatinib resistant/intolerant chronic myeloid leukemia
by: Monika Conchon, et al.
Published: (2011-01-01)

Allografting for Bosutinib, Imatinib, Nilotinib, Dasatinib, and Interferon Resistant Chronic Myeloid Leukemia without ABL Kinase Mutation
by: B. Uz, et al.
Published: (2011-01-01)

Long-term safety and efficacy of dasatinib in the treatment of chronic-phase chronic myeloid leukemia patients resistant or intolerant to imatinib
by: Shoumariyeh K, et al.
Published: (2014-09-01)

Therapeutic strategy for chronic myeloid leukemia: possibilities and prospects
by: A G Turkina, et al.
Published: (2013-07-01)

Severe thrombocytopenia after dasatinib treatment in a patient with Philadelphia chromosome-positive chronic myeloid leukemia
by: Chen R, et al.
Published: (2015-04-01)

Dasatinib-Induced Hypopigmentation in Pediatric Patient with Chronic Myeloid Leukemia: A Case Report and Review of the Literature
by: Bader Alharbi, et al.
Published: (2018-01-01)

A Case of Multiple Myeloma with Metachronous Chronic Myeloid Leukemia Treated Successfully with Bortezomib, Dexamethasone, and Dasatinib
by: Samer Alsidawi, et al.
Published: (2014-01-01)

Biphenotypic extramedullary blast crisis with MLL gene rearrangement in a case of chronic myeloid leukemia following Dasatinib therapy: An unusual case
by: Richa Juneja, et al.
Published: (2016-01-01)

Management of Chronic Myeloid Leukemia Patients During Pregnancy (Analysis of Literature and Practical Recommendations)
by: EYu Chelysheva, et al.
Published: (2019-03-01)

Dasatinib preferentially induces apoptosis by inhibiting Lyn kinase in nilotinib-resistant chronic myeloid leukemia cell line
by: Tanaka Yuko, et al.
Published: (2011-08-01)

Immediate Effects of Dasatinib on the Migration and Redistribution of Naïve and Memory Lymphocytes Associated With Lymphocytosis in Chronic Myeloid Leukemia Patients
by: Beatriz Colom-Fernández, et al.
Published: (2019-11-01)